GPR125 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.842600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.505000E-01
Normal-vs-Stage2
8.936600E-01
Normal-vs-Stage3
5.035200E-01
Normal-vs-Stage4
6.730400E-01
Stage1-vs-Stage2
9.969200E-01
Stage1-vs-Stage3
2.699400E-01
Stage1-vs-Stage4
3.720800E-01
Stage2-vs-Stage3
2.135600E-01
Stage2-vs-Stage4
4.707800E-01
Stage3-vs-Stage4
2.432600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.544800E-01
Normal-vs-AfricanAmerican
8.259600E-01
Normal-vs-Asian
8.419800E-01
Caucasian-vs-AfricanAmerican
2.467800E-01
Caucasian-vs-Asian
1.668960E-01
AfricanAmerican-vs-Asian
9.524200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.764600E-01
Normal-vs-Female
9.536200E-01
Male-vs-Female
8.256800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.674800E-01
Normal-vs-Age(41-60Yrs)
8.560000E-01
Normal-vs-Age(61-80Yrs)
8.198600E-01
Normal-vs-Age(81-100Yrs)
6.730800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.157800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.881000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.864800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.476470E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.288100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.671600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.023400E-01
Normal-vs-Daily Drinker
4.774600E-01
Normal-vs-Weekly Drinker
8.487800E-01
Normal-vs-Occasional Drinker
9.092800E-01
Normal-vs-Social Drinker
9.279800E-01
Non Drinker-vs-Daily Drinker
4.928800E-01
Non Drinker-vs-Weekly Drinker
5.231400E-01
Non Drinker-vs-Occasional Drinker
2.420400E-01
Non Drinker-vs-Social Drinker
7.328300E-02
Daily Drinker-vs-Weekly Drinker
3.009000E-01
Daily Drinker-vs-Occasional Drinker
1.172550E-01
Daily Drinker-vs-Social Drinker
4.279900E-02
Weekly Drinker-vs-Occasional Drinker
5.738200E-01
Weekly Drinker-vs-Social Drinker
3.967400E-01
Occasional Drinker-vs-Social Drinker
9.732200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.532400E-01
Normal-vs-Grade 2
9.480200E-01
Normal-vs-Grade 3
9.211400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.639000E-01
Grade 1-vs-Grade 3
2.623000E-01
Grade 1-vs-Grade 4
9.532400E-01
Grade 2-vs-Grade 3
6.242800E-01
Grade 2-vs-Grade 4
9.480200E-01
Grade 3-vs-Grade 4
9.211400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.130800E-01
Normal-vs-NonDiabetic
8.625600E-01
Diabetic-vs-NonDiabetic
4.009500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.963800E-01
Normal-vs-NoPancreatitis
8.602800E-01
Pancreatitis-vs-NoPancreatitis
4.617600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.814800E-01
Normal-vs-N1
9.153200E-01
N0-vs-N1
3.892800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.199600E-01
Normal-vs-TP53-NonMutant
8.573000E-01
TP53-Mutant-vs-TP53-NonMutant
5.661600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
